Eating Disorders: A Clinical Update-View Presentation

Video Transcription

Video Summary

In the video, the clinical updates session on eating disorders discusses the increase in cases during the COVID-19 pandemic and the need for proper identification and clinical management. The speakers present research findings on restrictive eating behavior and the role of anxiety in eating disorders. They discuss the use of exposure therapy as a treatment approach to help patients tolerate distress and interrupt safety behaviors. The importance of addressing habits in eating disorders is highlighted, and a behavioral intervention focused on changing habits to improve intake is discussed. The video also briefly touches on medications used to treat eating disorders, including olanzapine for anorexia nervosa and lisdexamphetamine for binge eating disorder.   <br /><br />In addition, the video covers the effects of olanzapine on BMI and weight gain. Patients taking olanzapine experienced a significant increase in BMI compared to those on placebo. The lack of significant differences in psychological symptom change between the two groups is also mentioned. However, somatic symptom improvements were reported by the participants receiving olanzapine, such as better sleep, concentration, and reduced restlessness.<br /><br />Furthermore, the treatment of binge eating disorder is discussed, mentioning the use of antidepressant medications to reduce binge frequency. A study on Vyvanse (lisdexamphetamine) is mentioned, showing a statistically significant improvement in binge eating days per week and a 5% weight loss.<br /><br />Lastly, the development of psychotherapies based on research findings related to pre-meal anxiety and the habit hypothesis for anorexia nervosa is touched upon. Exposure response prevention and the REACH Plus outpatient treatment approach are highlighted as methods to change habits and behaviors associated with eating disorders. The challenges of treating comorbid conditions in individuals with eating disorders, such as oppositional defiant disorder and selective mutism, are also briefly discussed.<br /><br />Credits to the faculty members involved in the clinical updates session are given: Dr. Evelyn Atiyah, Dr. Tim Walsh, Dr. Joanna Steinglass, and Dr. Eric Williams.

Keywords

clinical updates

eating disorders

COVID-19 pandemic

restrictive eating behavior

exposure therapy

habits

olanzapine

lisdexamphetamine

binge eating disorder

BMI

psychological symptoms

somatic symptoms

antidepressant medications